Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment. (Q42512737)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

John Carucci

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

2

Emma Guttman-Yassky

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

11

James G Krueger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Judilyn Fuentes-Duculan

5

object named as

Judilyn Fuentes-Duculan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

9

Irma Cardinale

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

8

Artemis Khatcherian

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

10

Inna Novitskaya

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1

Helen G Kaporis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

4

Asifa S Haider

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Kamruz Darabi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Julia Whynot-Ertelt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

17 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

Journal of Investigative Dermatology

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

2391-2398

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.jid.5700884

30 December 2019

exact match

0 references

cites work

Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Regulatory T cells in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Interleukin-12 in anti-tumor immunity and immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Selective transduction of murine myelomonocytic leukemia cells (WEHI-3B) with regular and RGD-adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Genomic Analysis Defines a Cancer-Specific Gene Expression Signature for Human Squamous Cell Carcinoma and Distinguishes Malignant Hyperproliferation from Benign Hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Human CD4+CD25high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Tolerogenic dendritic cells: cytokine modulation comes of age.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Endothelial stroma programs hematopoietic stem cells to differentiate into regulatory dendritic cells through IL-10

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Long-term follow-up of basal cell carcinomas treated with perilesional interferon alfa 2b as monotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Cytokine profiles in spontaneously regressing basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Cancer despite immunosurveillance: immunoselection and immunosubversion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700884

7 January 2021

Identifiers

DOI

10.1038/SJ.JID.5700884

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508019%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference